DGKB and cancer: Targeting DGKs may be important in cancer immunotherapy, as intratumoral injection of DGK knockout T-cells into U87MGvIII glioblastoma tumor models, obtained by CRISPR/Cas9, caused significant suppression of the tumors [25].